Abstract

The attenuated microbes used as vaccines have been derivatives or close relatives of the virulent organism, retaining enough immunologic similarity to induce specific immunity. Schneerson and Robbins, in this issue of the Journal, describe an interesting new approach: the induction of specific humoral immunity by colonization with a genetically unrelated but immunologically cross-reactive bacterium. The effort stems from a more fundamental question posed in previous reports by Dr. Robbins and colleagues, "how do we naturally acquire antibodies to the capsular polysaccharide of Haemophilus influenzae type b (H.i.b)?" They were struck by the apparent dilemma that these antibodies, which may be . . .

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.